Logo image of AUVI

APPLIED UV INC (AUVI) Stock Fundamental Analysis

NASDAQ:AUVI - Nasdaq - US0379883004 - Common Stock - Currency: USD

0.2926  -0.03 (-8.56%)

After market: 0.1521 -0.14 (-48.02%)

Fundamental Rating

1

Overall AUVI gets a fundamental rating of 1 out of 10. We evaluated AUVI against 41 industry peers in the Building Products industry. AUVI may be in some trouble as it scores bad on both profitability and health. AUVI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AUVI had negative earnings in the past year.
AUVI had a negative operating cash flow in the past year.
AUVI had negative earnings in 4 of the past 5 years.
AUVI had negative operating cash flow in 4 of the past 5 years.
AUVI Yearly Net Income VS EBIT VS OCF VS FCFAUVI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

AUVI has a worse Return On Assets (-25.38%) than 90.48% of its industry peers.
AUVI has a Return On Equity of -59.56%. This is amonst the worse of the industry: AUVI underperforms 90.48% of its industry peers.
Industry RankSector Rank
ROA -25.38%
ROE -59.56%
ROIC N/A
ROA(3y)-33.73%
ROA(5y)-14.6%
ROE(3y)-62.87%
ROE(5y)0.06%
ROIC(3y)N/A
ROIC(5y)N/A
AUVI Yearly ROA, ROE, ROICAUVI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 100 -100 200

1.3 Margins

Looking at the Gross Margin, with a value of 19.22%, AUVI is doing worse than 80.95% of the companies in the same industry.
In the last couple of years the Gross Margin of AUVI has declined.
The Profit Margin and Operating Margin are not available for AUVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.93%
GM growth 5Y-11.46%
AUVI Yearly Profit, Operating, Gross MarginsAUVI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80

More info and screens

2

2. Health

2.1 Basic Checks

AUVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AUVI has been reduced compared to 1 year ago.
AUVI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AUVI has been reduced compared to a year ago.
AUVI Yearly Shares OutstandingAUVI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
AUVI Yearly Total Debt VS Total AssetsAUVI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

AUVI has an Altman-Z score of -1.29. This is a bad value and indicates that AUVI is not financially healthy and even has some risk of bankruptcy.
AUVI has a Altman-Z score of -1.29. This is amonst the worse of the industry: AUVI underperforms 97.62% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that AUVI is not too dependend on debt financing.
The Debt to Equity ratio of AUVI (0.18) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -1.29
ROIC/WACCN/A
WACC16.34%
AUVI Yearly LT Debt VS Equity VS FCFAUVI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.61 indicates that AUVI may have some problems paying its short term obligations.
AUVI has a worse Current ratio (0.61) than 90.48% of its industry peers.
A Quick Ratio of 0.35 indicates that AUVI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.35, AUVI is doing worse than 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.35
AUVI Yearly Current Assets VS Current LiabilitesAUVI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AUVI have decreased strongly by -107.64% in the last year.
Looking at the last year, AUVI shows a very strong growth in Revenue. The Revenue has grown by 102.03%.
AUVI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.04% yearly.
EPS 1Y (TTM)-107.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17.8%
Revenue 1Y (TTM)102.03%
Revenue growth 3Y92.26%
Revenue growth 5Y40.04%
Sales Q2Q%55.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y38.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AUVI Yearly Revenue VS EstimatesAUVI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AUVI Yearly EPS VS EstimatesAUVI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AUVI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AUVI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AUVI Price Earnings VS Forward Price EarningsAUVI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AUVI Per share dataAUVI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AUVI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APPLIED UV INC

NASDAQ:AUVI (5/28/2024, 8:02:29 PM)

After market: 0.1521 -0.14 (-48.02%)

0.2926

-0.03 (-8.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)06-03 2024-06-03/bmo
Earnings (Next)08-12 2024-08-12
Inst Owners12.94%
Inst Owner Change0%
Ins Owners449.7%
Ins Owner Change0%
Market Cap490.97K
Analysts82.86
Price Target26.78 (9052.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.35
Dividend Growth(5Y)N/A
DP-5.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-11.46%
Min Revenue beat(2)-25.5%
Max Revenue beat(2)2.57%
Revenue beat(4)2
Avg Revenue beat(4)0.72%
Min Revenue beat(4)-25.5%
Max Revenue beat(4)32.73%
Revenue beat(8)4
Avg Revenue beat(8)8.36%
Revenue beat(12)6
Avg Revenue beat(12)12.26%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.02
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-14.68
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-5.23
FCFYN/A
OCF(TTM)-4.9
OCFYN/A
SpS24.26
BVpS14.83
TBVpS-7.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.38%
ROE -59.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.22%
FCFM N/A
ROA(3y)-33.73%
ROA(5y)-14.6%
ROE(3y)-62.87%
ROE(5y)0.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.93%
GM growth 5Y-11.46%
F-Score3
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.81%
Cap/Sales 1.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.35
Altman-Z -1.29
F-Score3
WACC16.34%
ROIC/WACCN/A
Cap/Depr(3y)7.66%
Cap/Depr(5y)244.6%
Cap/Sales(3y)0.58%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-107.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17.8%
EPS Next Y38.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)102.03%
Revenue growth 3Y92.26%
Revenue growth 5Y40.04%
Sales Q2Q%55.48%
Revenue Next Year6.38%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.98%
OCF growth 3YN/A
OCF growth 5YN/A